These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2051706)

  • 1. [Chemotherapeutic evaluation of pulmonary tuberculosis patients with a complication of hepatic dysfunction].
    Shichi I; Sato A; Chida K; Yasuda K; Tatsuta Y; Honda A; Wada R; Yamazaki A
    Kekkaku; 1991 Apr; 66(4):309-17. PubMed ID: 2051706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver function tests in patients of pulmonary tuberculosis using four different drug regimens.
    Akbri MZ; Fatima N; ul Haque E; Shiekh AS; Bhatti MS
    J Ayub Med Coll Abbottabad; 2001; 13(2):5-10. PubMed ID: 11732224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pyrazinamide-containing initial intensive short course chemotherapy of pulmonary tuberculosis].
    Wada M
    Kekkaku; 1997 Oct; 72(10):587-95. PubMed ID: 9386358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
    Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of causes of death in patients with pulmonary tuberculosis].
    Takahara M
    Kekkaku; 2004 Dec; 79(12):711-6. PubMed ID: 15782616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Follow-up study of short course chemotherapy of pulmonary tuberculosis complicated with diabetes mellitus].
    Kameda K; Kawabata S; Masuda N
    Kekkaku; 1990 Dec; 65(12):791-803. PubMed ID: 2077255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Home oxygen therapy in pulmonary tuberculosis and pulmonary atypical mycobacteriosis during chemotherapy].
    Suzuki K; Yamagishi F; Sasaki Y; Miyazawa H; Sugito K; Ihara S
    Kekkaku; 1994 May; 69(5):357-60. PubMed ID: 8007521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary tuberculosis with chemotherapy related liver dysfunction].
    Yasuda K; Sato A; Chida K; Shichi I; Kishimoto H; Wada R; Tatsuta Y; Honda A; Yamazaki A
    Kekkaku; 1990 Jun; 65(6):407-13. PubMed ID: 2388450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pneumoconiosis and mycobacterial infection].
    Kekkaku; 2003 Nov; 78(11):711-5. PubMed ID: 14672049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy of newly detected destructive pulmonary tuberculosis in patients with pathology of the gastrointestinal tract and liver].
    Potashova VA; Zhukova EM; Borovinskaia TA; Fomintseva OA; Fedorova MV
    Probl Tuberk; 1990; (7):65-6. PubMed ID: 2235957
    [No Abstract]   [Full Text] [Related]  

  • 14. [A clinical study of causes of death from active pulmonary tuberculosis with chemotherapy].
    Sato A; Inoue T; Kurasawa T; Ikeda N; Nakatani K; Ikeda T; Yoshimatsu T
    Kekkaku; 1998 Dec; 73(12):733-8. PubMed ID: 10028808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
    Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H
    Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation on causes of death in patients with active pulmonary tuberculosis].
    Kuba M; Nakasone K; Miyagi S; Kyan K; Shinzato T; Kohagura N; Futenma M; Genka K
    Kekkaku; 1996 Apr; 71(4):293-301. PubMed ID: 8683906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Administration of antituberculous drugs to subjects with basic diseases. 2. Clinical studies of INH and RFP therapy on tuberculous patients with liver diseases].
    Yamazaki M
    Kekkaku; 1987 Dec; 62(12):667-71. PubMed ID: 3448352
    [No Abstract]   [Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Liver function at the stage of intensive tuberculosis treatment of patients with diabetes mellitus].
    Karachunskiĭ MA; Kaminskiĭ GO; Kossiĭ IuE
    Probl Tuberk; 2000; (6):39-41. PubMed ID: 11209745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.